XORTX Therapeutics Valuation
| XRTX Stock | USD 1.21 0.02 1.68% |
Today, the company appears to be undervalued. XORTX Therapeutics maintains a prevalent Real Value of $2.42 per share. The last-minute price of the company is $1.21. Our model calculates the value of XORTX Therapeutics from analyzing the company fundamentals such as Return On Asset of -0.33, current valuation of 1.59 M, and Shares Owned By Insiders of 3.01 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting XORTX Therapeutics' valuation include:
Price Book 1.7979 | Enterprise Value 1.6 M | Enterprise Value Ebitda 0.0864 | Forward PE 0.9621 | Trailing PE 10.5 |
Undervalued
Today
Please note that XORTX Therapeutics' price fluctuation is dangerous at this time. Calculation of the real value of XORTX Therapeutics is based on 3 months time horizon. Increasing XORTX Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since XORTX Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of XORTX Stock. However, XORTX Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.21 | Real 2.42 | Target 6.16 | Hype 1.17 |
The intrinsic value of XORTX Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence XORTX Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of XORTX Therapeutics helps investors to forecast how XORTX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of XORTX Therapeutics more accurately as focusing exclusively on XORTX Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use XORTX Therapeutics' intrinsic value based on its ongoing forecasts of XORTX Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against XORTX Therapeutics' closest peers.
XORTX Therapeutics Cash |
|
XORTX Valuation Trend
Analysing the historical paterns of XORTX Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of XORTX Therapeutics over time and is usually enough for investors to make rational market timing decisions.
XORTX Therapeutics Total Value Analysis
XORTX Therapeutics is at this time anticipated to have valuation of 1.59 M with market capitalization of 4.34 M, debt of 11.51 K, and cash on hands of 13.42 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the XORTX Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.59 M | 4.34 M | 11.51 K | 13.42 M |
XORTX Therapeutics Asset Utilization
One of the ways to look at asset utilization of XORTX is to check how much profit was generated for every dollar of assets it reports. XORTX Therapeutics maintains a negative usage of resources of -0.33 (%), losing $0.003314 for each dollar of resources held by the company. Inadequate asset utilization attests that the company is being less efficient with each dollar of resources it maintains. Specifically, asset utilization of XORTX Therapeutics shows how discouraging it operates for each dollar spent on its resources.XORTX Therapeutics Ownership Allocation
XORTX Therapeutics maintains 3.01 (%) of its outstanding shares held by insiders and 6.03 (%) owned by institutional investors.XORTX Therapeutics Profitability Analysis
Net Loss for the year was (2.16 M) with profit before overhead, payroll, taxes, and interest of 0.About XORTX Therapeutics Valuation
Our relative valuation model uses a comparative analysis of XORTX Therapeutics. We calculate exposure to XORTX Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of XORTX Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -142 K | -134.9 K |
XORTX Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2 M | |
| Forward Price Earnings | 0.9621 |
XORTX Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of XORTX Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value XORTX we look at many different elements of the entity such as XORTX's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as XORTX Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use XORTX Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes XORTX Therapeutics' worth.Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.